SCHEMBL4269337

SCHEMBL4269337

COCC1COc2cscc2O1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.33
MAPK1 P28482 1/20 0.33
MAOA P21397 1/20 0.33
GSK3A P49840 3/20 0.32
GSK3B P49841 3/20 0.32
AURKA O14965 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
MTNR1A P48039 2/20 0.32
POLB P06746 1/20 0.32
ESR2 Q92731 1/20 0.32
HPGD P15428 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14748770 0.86 ALDH1A1 (0.33) L3MBTL1MAPK1ADRA2AADRA2BADRA2C
SCHEMBL23822909 0.85 ALDH1A1 (0.33) MAPK1ADRA2AADRA2BADRA2CALDH1A1
SCHEMBL1633925 0.85 ALDH1A1 (0.33) MAPK1ADRA2AADRA2BADRA2CALDH1A1
SCHEMBL4260153 0.83 ALDH1A1 (0.38) L3MBTL1MAPK1MTNR1APOLBESR2
SCHEMBL17853293 0.83 MAOA (0.31) MAOA
SCHEMBL5895577 0.81 TSHR (0.37) L3MBTL1MAPK1ALDH1A1CYP3A4CYP2D6
SCHEMBL4257289 0.81 ALDH1A1 (0.39) POLBESR2ALDH1A1CYP1A2CYP3A4
SCHEMBL17853289 0.80
SCHEMBL417702 0.80 POLB (0.37) ADRA2AADRA2BADRA2CMTNR1APOLB
SCHEMBL12361954 0.80 ALDH1A1 (0.36) L3MBTL1MAPK1ADRA2AMTNR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160233545-A1 ELECTROLYTE ADDITIVE AND USE THEREOF NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2016-08-11 US claimed
EP-2758832-B1 FLEXIBLE TRANSPARENT ELECTROCHOMIC DEVICE, AND A METHOD FOR THE PREPARATION THEREOF HYDRO QUEBEC (CA) 2020-08-05 EP disclosed
US-20160233545-A1 ELECTROLYTE ADDITIVE AND USE THEREOF NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2016-08-11 US disclosed
US-20160233545-A1 ELECTROLYTE ADDITIVE AND USE THEREOF NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2016-08-11 US disclosed
US-20160233545-A1 ELECTROLYTE ADDITIVE AND USE THEREOF NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2016-08-11 US disclosed
US-9249353-B2 Flexible transparent electrochomic device, and a method for the preparation thereof HYDRO-QUEBEC (CA) 2016-02-02 US disclosed
WO-2013041562-A1 FLEXIBLE TRANSPARENT ELECTROCHOMIC DEVICE, AND A METHOD FOR THE PREPARATION THEREOF HYDRO-QUEBEC (CA) 2013-03-28 WO disclosed
EP-2570846-A1 Flexible transparent electrochromic device Hydro-Québec (CA) 2013-03-20 EP disclosed
EP-1327645-B1 Process for the production of neutral poly(ethylenedioxythiophene) and related poly(ethylenedioxythiophenes) STARCK H C GMBH (DE) 2009-10-21 EP disclosed
US-6756473-B2 REACTING WITH OXIDIZER; APPLYING TO SUBSTRATE BAYER AKTIENGESELLSCHAFT (DE) 2004-06-29 US disclosed
US-20030139505-A1 Process for the preparation of neutral polyethylenedioxythiophene, and corresponding polyethylenedioxythiophenes HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2003-07-24 US disclosed
EP-1327645-A1 Process for the production of neutral poly(ethylenedioxythiophene) and related poly(ethylenedioxythiophenes) Bayer Aktiengesellschaft (DE) 2003-07-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233545-A1 ELECTROLYTE ADDITIVE AND USE THEREOF HCN4, TST, SLC6A12 L3MBTL1 2471/4885MAPK1 826/4885MAOA 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.